CARISMA Therapeutics to Participate in Upcoming Investor Conferences

October 5, 2020

PHILADELPHIA, Oct. 5, 2020 /PRNewswire/ — CARISMA Therapeutics Inc., a biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that the company will present at two virtual investor conferences in October 2020. Click here for more information.